GE Healthcare has acquired Puridify, a bioprocessing start-up that is developing a nanofiber-based platform purification technology called FibroSelect for biopharmaceutical production.   Puridify has collaborated with several major biopharmaceutical manufacturers in the development of FibroSelect, and their platform is expected to bring productivity improvements in the process development (PD) phase and small-scale manufacturing for a wide variety of biopharmaceutical applications.  ...